Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

BUY
$14.32 - $19.88 $31,461 - $43,676
2,197 Added 18.09%
14,340 $212,000
Q1 2022

Apr 21, 2022

SELL
$15.39 - $20.25 $34,935 - $45,967
-2,270 Reduced 15.75%
12,143 $235,000
Q4 2021

Feb 14, 2022

BUY
$15.91 - $18.72 $229,310 - $269,811
14,413 New
14,413 $249,000
Q4 2021

Feb 03, 2022

SELL
$15.91 - $18.72 $229,963 - $270,578
-14,454 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$13.06 - $17.24 $261,173 - $344,765
-19,998 Reduced 58.05%
14,454 $242,000
Q2 2021

Aug 10, 2021

BUY
$11.45 - $13.96 $11,953 - $14,574
1,044 Added 3.13%
34,452 $462,000
Q1 2021

Apr 30, 2021

BUY
$11.06 - $12.87 $127,433 - $148,288
11,522 Added 52.65%
33,408 $399,000
Q4 2020

Feb 12, 2021

BUY
$9.33 - $12.48 $204,196 - $273,137
21,886 New
21,886 $271,000
Q3 2020

Nov 16, 2020

SELL
$10.33 - $14.49 $141,541 - $198,541
-13,702 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$11.49 - $15.26 $35,722 - $47,443
-3,109 Reduced 18.49%
13,702 $192,000
Q1 2020

May 08, 2020

BUY
$8.11 - $15.23 $35,684 - $67,012
4,400 Added 35.45%
16,811 $198,000
Q4 2019

Jan 24, 2020

SELL
$10.28 - $14.38 $50,505 - $70,648
-4,913 Reduced 28.36%
12,411 $176,000
Q3 2019

Nov 13, 2019

BUY
$10.05 - $14.55 $53,254 - $77,100
5,299 Added 44.07%
17,324 $183,000
Q2 2019

Jul 16, 2019

BUY
$13.1 - $14.95 $12,117 - $13,828
925 Added 8.33%
12,025 $175,000
Q1 2019

May 16, 2019

BUY
$13.69 - $20.06 $151,959 - $222,666
11,100 New
11,100 $156,000
Q1 2018

Apr 13, 2018

SELL
$13.8 - $16.99 $58,484 - $72,003
-4,238 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$11.73 - $14.75 $49,711 - $62,510
4,238
4,238 $60,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.